Mizuho Securities Starts UiPath Inc. (PATH) at Buy

Mizuho Securities analyst Siti Panigrahi initiates coverage on UiPath Inc. (NYSE: PATH) with a Buy rating and a price target of $77.00.

The analyst comments "UiPath offers a robotic process automation (RPA) platform that we believe has best-in-class functionality, ease of use and scalability. We expect the company to sustain robust levels of revenue growth and improve its operating margins from growing demand for its automation platform. Noting its sticky, best-of-breed technology, early-mover advantage, multiple growth levers, large TAM and improving operating profile, we see PATH as an attractive long-term investment at its current price."

For an analyst ratings summary and ratings history on UiPath Inc. click here. For more ratings news on UiPath Inc. click here.

Shares of UiPath Inc. closed at $70.48 yesterday.

You May Also Be Interested In

• Stifel Starts Arrowhead Pharma (ARWR) at Buy
• PBF Energy (PBF) PT Raised to $57 at Mizuho
• Krystal Biotech (KRYS) PT Raised to $396 at BofA Securities